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NOTES AND COMMENTS

Pitfall regarding expression of ETS-related gene (ERG) in
fibrohistiocytic neoplasms
I read with great interest the recent paper entitled “EWSR1-SMAD3

superficial samples and the presence of spindled cells in hypercellular,

rearranged fibroblastic tumor: Case series and review,” which is the

well-organized, and intersecting fascicles can be seen in cellular

largest case series to date reviewing the histopathological features

fibrous histiocytoma. Moreover, fibrous histiocytoma can arise on

of this newly described entity.1 Dermatopathologists should wel-

acral surfaces, is easily the most commonly biopsied fibrous tumor of

come this contribution given the common occurrence of spindled

the skin, and may not reliably stain for commonly used fibrohistiocytic

cell tumors that are difficult to precisely classify in clinical practice.

markers on immunohistochemistry.

Furthermore, the authors provide a nice overview of the differential

The authors emphasize that ETS-related gene (ERG) is uniformly

diagnosis for this tumor in Table 2 and cite two other papers dis-

expressed in ESFT in contrast to many of the other entities on the dif-

cussing potential mimickers.2,3

ferential diagnosis. There is a paucity of literature regarding ERG

I find it interesting that none of the groups that have published

expression in fibrohistiocytic proliferations in general, though we

on EWSR1-SMAD3 rearranged fibroblastic tumor (ESFT) have included

recently encountered an acral cellular fibrous histiocytoma at our

cellular fibrous histiocytoma in the differential diagnosis. Certainly,

institution that demonstrated strong and diffuse staining for ERG

there appear to be morphological/architectural features which may in

(Figure 1). Moreover, given the lack of expression of other commonly

some circumstances assist in discriminating the two (notably the zona-

used markers in this setting (Fac13a, CD34, SMA, CD163, CD68) a

tion with foci of hyalinization) on a complete excision. However, many

next-generation sequencing panel was ordered, which failed to detect

of the biopsy specimens that dermatopathologists receive are

the EWSR1-SMAD3 translocation. There is one published abstract

F I G U R E 1 Top panel demonstrates a
dermal-based proliferation of spindled cells
in fascicles pressed up against the
epidermis with peripheral collagen trapping
(hematoxylin and eosin [H&E], ×40, original
magnification). Lower right panel shows
relatively monomorphous plump spindled
cells in hypercellular fascicles (H&E, ×200,
original magnification). Lower left panel
shows intense expression of ERG (H&E,
×200, original magnification)
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which reported consistent expression of ERG in fibrous histiocytoma

OR CID

and giant cell tumor of the tendon sheath.4 Moreover, it is well
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established that some case of epithelioid sarcoma express ERG. If
additional neoplasms of fibrohistiocytic origin are found to express
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ERG, it would become a much less helpful adjunct in this setting. This

1. Habeeb O, Korty KE, Azzato EM, et al. EWSR1-SMAD3 rearranged fibroblastic tumor: case series and review. J Cutan Pathol. 2021;48(2):255-262.
2. Kao YC, Flucke U, Eijkelenboom A, et al. Novel EWSR1-SMAD3 gene
fusions in a group of acral fibroblastic spindle cell neoplasms. Am J Surg
Pathol. 2018;42(4):522-528.
3. Michal M, Berry RS, Rubin BP, et al. EWSR1-SMAD3-rearranged fibroblastic tumor: an emerging entity in an increasingly more complex
group of fibroblastic/myofibroblastic neoplasms. Am J Surg Pathol.
2018;42(10):1325-1333.
4. Beshai B, Cartun R, Mandavilli S. ERG immunohistochemical (IHC)
expression in fibrohistiocytic tumors: a diagnostic pitfall. Am J of Clin
Pathol. 2015;144(2,1):A309.
5. Miettinen M, Wang Z, Sarlomo-Rikala M, Abdullaev Z, Pack SD,
Fetsch JF. ERG expression in epithelioid sarcoma: a diagnostic pitfall.
Am J Surg Pathol. 2013;37(10):1580-1585.

would be important to establish to mitigate the use of costly sequencing panels.
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